» Articles » PMID: 25215613

IBD Candidate Genes and Intestinal Barrier Regulation

Overview
Specialty Gastroenterology
Date 2014 Sep 13
PMID 25215613
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Technological advances in the large scale analysis of human genetics have generated profound insights into possible genetic contributions to chronic diseases including the inflammatory bowel diseases (IBDs), Crohn's disease and ulcerative colitis. To date, 163 distinct genetic risk loci have been associated with either Crohn's disease or ulcerative colitis, with a substantial degree of genetic overlap between these 2 conditions. Although many risk variants show a reproducible correlation with disease, individual gene associations only affect a subset of patients, and the functional contribution(s) of these risk variants to the onset of IBD is largely undetermined. Although studies in twins have demonstrated that the development of IBD is not mediated solely by genetic risk, it is nevertheless important to elucidate the functional consequences of risk variants for gene function in relevant cell types known to regulate key physiological processes that are compromised in IBD. This article will discuss IBD candidate genes that are known to be, or are suspected of being, involved in regulating the intestinal epithelial barrier and several of the physiological processes presided over by this dynamic and versatile layer of cells. This will include assembly and regulation of tight junctions, cell adhesion and polarity, mucus and glycoprotein regulation, bacterial sensing, membrane transport, epithelial differentiation, and restitution.

Citing Articles

Exploring genetic structures and shared sites between alcohol, cheese intake, and inflammatory bowel disease.

Huang Z, Yuan W Front Nutr. 2025; 12:1468457.

PMID: 39917747 PMC: 11798781. DOI: 10.3389/fnut.2025.1468457.


The Cell-Specific Effects of JAK1 Inhibitors in Ulcerative Colitis.

Veltkamp S, Voorneveld P J Clin Med. 2025; 14(2).

PMID: 39860613 PMC: 11766026. DOI: 10.3390/jcm14020608.


The effect size of rs521851 in the intron of MAGI2/S-SCAM on HADS-D scores correlates with EAT-26 scores for eating disorders risk.

Pinakhina D, Kasyanov E, Rukavishnikov G, Larin A, Veselovsky V, Rakitko A Front Psychiatry. 2024; 15:1416009.

PMID: 39703455 PMC: 11656592. DOI: 10.3389/fpsyt.2024.1416009.


infection alters the intestinal mucosa transcriptome in neonatal calves: impacts on epithelial barriers and transcellular transport systems.

Veshkini A, Kuhn C, Dengler F, Bachmann L, Liermann W, Helm C Front Cell Infect Microbiol. 2024; 14:1495309.

PMID: 39703373 PMC: 11656319. DOI: 10.3389/fcimb.2024.1495309.


Underneath the Gut-Brain Axis in IBD-Evidence of the Non-Obvious.

Boldyreva L, Evtushenko A, Lvova M, Morozova K, Kiseleva E Int J Mol Sci. 2024; 25(22).

PMID: 39596193 PMC: 11594934. DOI: 10.3390/ijms252212125.


References
1.
Hoeve J, Ibarra-Sanchez M, Fu Y, Zhu W, Tremblay M, David M . Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol. 2002; 22(16):5662-8. PMC: 133976. DOI: 10.1128/MCB.22.16.5662-5668.2002. View

2.
Simoncic P, Lee-Loy A, Barber D, Tremblay M, McGlade C . The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr Biol. 2002; 12(6):446-53. DOI: 10.1016/s0960-9822(02)00697-8. View

3.
Walker N, Simpson J, Brazill J, Gill R, Dudeja P, Schweinfest C . Role of down-regulated in adenoma anion exchanger in HCO3- secretion across murine duodenum. Gastroenterology. 2009; 136(3):893-901. PMC: 2694732. DOI: 10.1053/j.gastro.2008.11.016. View

4.
Garrison W, Battle M, Yang C, Kaestner K, Sladek F, Duncan S . Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. Gastroenterology. 2006; 130(4):1207-20. PMC: 3581272. DOI: 10.1053/j.gastro.2006.01.003. View

5.
Schaffler A, Zeitoun M, Wobser H, Buechler C, Aslanidis C, Herfarth H . Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases. Cardiovasc Diabetol. 2007; 6:3. PMC: 1802733. DOI: 10.1186/1475-2840-6-3. View